Regenstrief Institute of Indianapolis is partnering with MDClone in Israel in an effort to speed up the access to data for medical research. The institute plans to use MDClone’s platform, which it says protects the privacy of data and reduces IT and regulatory burdens. Peter Embi, chief executive officer of Regenstrief Institute, says the partnership will enhance its efforts to accelerate research and innovation by "significantly shortening the time to deliver research-ready, privacy-preserving synthetic data," which will enable new discoveries, improve quality and reduce costs.
MDClone says its platform creates synthetic data sets based on original data of interest. The synthetic data tells the same "statistical story" as the original data, but does not contain any real information about the patient. The institute plans to apply the platform to a trove of data it manages for some of its health partners to demonstrate its effectiveness.
The partnership will then work on data-driven initiatives with the Indiana University School of Medicine, IU Health, Eskenazi Health and the Indiana Health Information Exchange.
"This is an extremely valuable opportunity for Regenstrief and its partners, and adds another dimension to our already considerable data capabilities and resources," said Embi. "Regenstrief and its partners have long been pioneers in health information exchange and research, and are entrusted with one of the largest sets of health care data in the world. This partnership should make Indiana and the region a magnet for data innovation nationally."
The partners are currently working to install the new data platform. You can learn more about the partnership by clicking here.